SafeCure Services IPO: ₹60 Cr Offer Opens Oct 29
Delhi-based pharmaceutical support company SafeCure Services Ltd plans to raise up to ₹60 crore through IPO. Fresh issue of 48 lakh shares priced at ₹60-75 each. Learn key dates and details.
Category : Search result: pharmaceutical registration
Punjab bans 112 substandard drugs in health safety drive
In a major healthcare move, Punjab government prohibits sale of 112 substandard drugs following quality control tests. Find out which medications are affected and what this means for public health safety.
Novartis Nears $1.7B Avidity Biosciences Acquisition
Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.
NCB grills health staff in Amritsar tramadol racket
Narcotics Control Bureau investigates two Punjab Health Department employees for alleged involvement in illegal tramadol distribution network. Shocking revelations emerge during interrogation.
CDSCO flags 112 drugs, spurious cough syrup after child deaths
India's drug regulator CDSCO has flagged 112 medicines for quality violations and issued a nationwide alert about a spurious cough syrup following child fatalities in Madhya Pradesh. Critical safety update for consumers.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Dr. Reddy's Q2 Earnings Beat Estimates, Revenue Rises
Dr. Reddy's Laboratories delivers stellar Q2 FY25 results, beating revenue and profit forecasts. Discover how their pharmaceutical business and nicotine replacement portfolio drove exceptional performance.
FDA Recalls 140K+ Cholesterol Drug Bottles
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
UP Drug Crackdown: Yogi Orders System Overhaul
In a major healthcare reform, Uttar Pradesh Chief Minister Yogi Adityanath mandates complete digitalization of drug regulation system and stricter quality control measures to ensure medicine safety across the state.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Q2: Profit Halves, Revenue Down 19%
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla Shares Fall 3% Despite Eli Lilly Weight Loss Drug Deal
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Delhi HC Stays NPPA's ORS Branding Ban - Relief for Manufacturers
Delhi High Court puts temporary stay on NPPA's order restricting 'ORS' branding for manufacturers. JJ Arm and other companies get breathing room in crucial rehydration market.
Aurobindo Pharma Expands to Chile with New Subsidiary
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Drug kingpin arrested in Mumbai after ₹252 crore seizure
Mumbai Crime Branch arrests wanted drug smuggler Lalit Patil after massive nationwide manhunt in connection with record ₹252 crore pharmaceutical drug seizure case.
Chandigarh Pharma Quality Summit Sets New Standards
Leading pharmaceutical experts gathered in Chandigarh for a crucial conference on drug quality and regulatory compliance, focusing on improving manufacturing practices and patient safety across India.
Torrent Pharma gets CCI nod for JB Chemicals stake
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
Indian Pharma Wins Crucial Legal Battle for Generic Drugs
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Biocon's US Insulin Move with Civica Partnership
Indian pharmaceutical leader Biocon Biologics partners with Civica to disrupt US insulin market with affordable alternatives, while also eyeing anti-obesity therapy opportunities.
Chandigarh Fancy Number E-Auction from Oct 29
Chandigarh launches online auction for premium vehicle registration numbers. Bid for VIP numbers like 0001, 0786, and exclusive series starting October 29. Complete guide to participation.
WHO: India's cough syrup safety still concerning
World Health Organization reports India making progress on drug regulation but warns more action needed to prevent toxic cough syrup incidents that have claimed lives globally.
Nigerian Drug Cartels Recruit Indian Pharma Students: Delhi Police
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Nuh launches paperless property registration from Oct 30
Haryana's Nuh district pioneers digital transformation with paperless property registration system, eliminating physical documents and streamlining real estate transactions.
Zydus vs Rubicon: Pharma Stock Analysis
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
Indian Pharma Q2 Preview: Steady Growth Amid Challenges
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
UP seizes ₹3 crore banned cough syrup in major drug bust
Uttar Pradesh authorities intercept massive consignment of prohibited cough syrup worth ₹3 crore in ongoing war against illegal pharmaceutical trade.
UP seizes ₹3 crore cough syrup in major drug bust
Massive drug crackdown in Uttar Pradesh as officials confiscate illegal cough syrup worth ₹3 crore from a Sonbhadra warehouse. Investigation reveals sophisticated smuggling operation.
Biocon chief denies Karnataka deputy CM's allegations
Biocon Executive Chairperson Kiran Mazumdar-Shaw firmly denies Karnataka Deputy CM DK Shivakumar's claims about the company's Bengaluru expansion plans, asserting their commitment to the state is unwavering.
India's New Prescription for Children's Cough Syrups
Discover how India is transforming its approach to pediatric cough syrups with new regulations, bitter-tasting alternatives, and enhanced safety measures following global health concerns.
MP SIT to Make More Arrests in Pharma Tragedy
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
Page 4 of 4